Manufacturers
Why do patients struggle with medication adherence even when they know it will help them? In part one of a two-part article series from Lash Group, discover how the most advanced patient support programs use behavioral science to unlock adherence.
Read the latest operational updates and find out more about World Courier’s risk management and business continuity plan
How to Maintain Supply Channels During COVID-19 – Keeping Things Moving During Times of Crises
How World Courier is Maintaining Global Supply Channels – Protecting You and Your Patients from Supply Chain Disruption.
The impact of logistics on the ability of advanced therapies to treat patients reinforces the message that therapy developers need to think about their entire supply chain and ‘Logistics by Design’ .
On 5 November 2018, the current EU GDP Guideline turned five years old. What have we learned in those five years? Have we succeeded in achieving a better protection of the integrity of pharmaceutical products and fortified patient safety? What did it mean for the R&D industry, the drug manufacturers and their service partners in the supply chain?
Logistics by Design (LbD) is a framework for logistics decision making. Using a risk based analysis it identifies the areas within the supply chain that need to be addressed to create a logistics platform that can meet the needs of patients at clinical and commercial scale.
Learn about some of the more interesting seasonal traditions from all around the globe
To truly understand the distribution challenges faced by today’s pharmaceutical industry in bringing a new product to the clinical or commercial market, this four-part blog series will explore the most impacted areas of the supply chain following a temperature excursion, starting with financial costs to the clinical sponsor.
The premise of the Direct-to-Patient model is straightforward, but it does require organizations to review and plan for three key considerations. Read our article as we discuss what they are and how to overcome them.
There is now a clearer vision for how IMP should be handled. Find out how the updated GDP guidelines bring clarity and accountability to IMP shipments.
Learn how World Courier's multi-year business transformation program (NOVA) will bring service enhancements and efficiencies to customers.
Watch Remo Hanselmann explain how World Courier meticulously plans each shipment that it has to deliver in the complex clinical trial logistical landscape.
Every CEO will be able to describe their target patient population, their clinical capability and their strategy for developing a manufacturing process, but how many can describe their strategy for connecting all of this to the patient? That is, what is their logistics vision?
Rudiger Lomb, Vice President, Global Quality and Technical Compliance at World Courier, discusses the current regulatory challenges that are impacting the specialty logistics industry.
What should you look for when attempting to integrate Direct-to-Patient services into your study or commercial delivery system? We discuss the success factors that you need to be aware of in the early stages of planning for DtP.
At World Courier, customer service is at the heart of our company. Watch Mattias Mineur, Sub-Regional Director Nordics, explain how World Courier provides an industry leading service and why we treat every shipment as if it was our own.
We highlight the benefits that sponsors and manufacturers are likely to receive if Direct-to-Patient is introduced as a supply chain method.
Learn why global GDP certification is important for the logistics industry and how World Courier goes beyond this framework.
The Direct-to-Patient approach can make life easier for patients and their loved ones. We've ranked the top seven benefits patients are likely to see.
Learn what Direct-to-Patient services are and the benefits you could expect by using this innovative practice
Take a look at the recent development of Cell and Gene Therapy and how this relatively new medical field will see patients benefiting for years to come.
Find out how to create competitive advantage by developing a fit-for-purpose supply chain that supports the market’s paradigm shift.
Overcoming logistical challenges through technology
Watch Mike Sweeney, World Courier’s Patient Centric Logistics Director, explain the value of implementing DtP and the innovations you can expect to see going forward.
In September 2017, Hurricane Maria caused devastating damage to Puerto Rico. Watch how World Courier and ICS delivered vital drugs to patients suffering from chronic central nervous system disease in less than 24 hours from planning to delivery.
Decade after decade, we’ve redefined what’s possible in specialty logistics. Learn more about World Courier's origins and how we've become the most trusted specialty logistics company in the world.
Specialist centres will create and deliver systems to progress advanced therapy development through joint ventures set up by industry, academic and NHS partners
Learn about the 12 steps to mobilize for success in direct-to-patient clinical trials
World Courier uses our expertise and experience to deal with custom requirements before the commercial supply chain has to think about them. Hear from Sam Herbert, President of World Courier as he discusses the lessons we have learnt.
The key difference in cell and gene therapy is that the patient is in the supply chain. Find out more from Sam Herbert, President of World Courier.
An overview of the planning required for the time-critical shipments involved in EPL
With Just-In-Time manufacturing and parts originating from half a world away, delays can easily cause a production line stoppage. With outages leading to loss of potential revenue and contract penalties, your reputation can be seriously affected.
As cell and gene therapy manufacturers bring their innovative products to market, they need to work with a trusted partner who can integrate a holistic solution.
This article discusses the key to avoiding temperature excursions and then planning for the most common challenges.
Sam Herbert, President of World Courier, gives insight into how cell and gene therapies can present new and difficult challenges for manufacturers and what can be done to support manufacturers from a supply chain perspective
Volker Kirchner, shares his insight into strategies for selecting temperature-control technologies.This article first appeared in BioPharm International, October 1, Caroline Hroncich
You’re investing hundreds of millions of dollars to develop products to enhance patient care and improve global health. But can your logistics partner meet the challenges?
The success of a clinical study depends on the CRO’s or sponsor’s ability to bring together people, processes, and technology in a coordinated effort to improve patient outcomes, one case at a time.
In this webinar on-demand World Courier’s Cell and Gene Therapy specialists share their knowledge with you, and discuss how our practical experience of Cell and Gene shipments is evolving logistics.
In this webinar, World Courier and Medical Research Network guide participants through the key regulatory considerations when planning direct to patient trials.
To help you understand why personalized therapies require a personalized supply chain, we’ve published Tomorrow’s Medicine: Curing One Patient at a Time – an e-book highlighting the logistics challenges of cell and gene therapies.
An overview of the risks inherent to global pharmaceutical logistics and the associated risk management. Get your white paper now.
December 2016, a new born baby in Toronto was diagnosed with a rare disease. Just before Christmas, the baby needed vital medicine that was not yet approved in Canada. Find out how we played a role in making sure the baby received its medicine.
Explore how practical knowledge and experience are the keys to successfully improving patient experience and moving medicine forwards.
Significant changes have been made in 2017, we've listed out all the changes that you need to be aware of based on the 58th edition first print of the DGR IATA book
This white paper shares 10 best practices to consider when developing your own contingency plan.
Michael Sweeney of World Courier and Stuart Redding of the Medical Research Network Share Insights on the Evolution of Community Based Trials
Southeast Asia is a growing pharmaceutical market with an increase in clinical trials in recent years. But what opportunities are there for multinational companies to embark on activity outside of the already well recognized study destinations?
Top 10 questions and answers to consider when conducting direct to patient clinical trials
Delivering cell and gene therapies - navigating logistics challenges when the patient is in the supply chain
A panel of experts discuss what it takes to be fully GxP compliant and what that means to manufacturers
An interview with Maurizio Orlandi, The Managing Director for World Courier Italy.
Today’s Russian clinical trial market is worth 880 million dollars and there is every expectation that it will continue to grow. The only question is, at what rate?
The CSS Archiving Project is a massive undertaking, containing thousands of trials and billions of trial data pieces from 14 locations over the world. Find out how it will impact you...
Orphan drugs are growing in importance worldwide. However, bringing an orphan drug to market unique challenges and considerations. Read our article to find out more.
Japan is the world's second largest single-country pharmaceutical market, accounting for approximately 10 per cent of global drug sales, and is expanding very quickly.
How direct-to-patient practices improve clinical trials for researchers and manufacturers.
Manufacturer requests are changing in specialty logistics. Are you prepared to meet expectations?
When a client wanted to ship a prototype car from Germany to New Zealand, no one could figure out how to fit the shipping container into the cargo hold or a regular transport plane. Find how World Courier saved the day and saved the client thousands of dollars in the process
What are some of the challenges of shipping into Latin America?Find out in this short video.
Top considerations for selecting the right packaging
Find out the three things that shippers need to know when selecting a specialty logistics provider
Ruediger Lomb, Vice President, Global Quality and Technical Compliance, AmerisourceBergen Specialty Group, shares the benefits and considerations of developing smart technology.
Join patient advocate Jack Whelan, Helna Baker of MRN’s Global Nursing Services and Sue Lee of World Courier as they combine their real-life experience and expertise to provide actionable insights on how companies can improve the patient experience in clinical trials.
This article first appeared on the Journal for Clinical Studies, Oct 2015
Volker Kirchner, Director, Temperature Control at World Courier discusses what we are seeing - and what to watch out for...
What role does Australia play in the growth of global healthcare, and how is the market continuing to change?
How are procurement teams changing the clinical trial landscape for the better?
The 57th edition of the IATA Dangerous Goods Regulations incorporates all amendments made by the Dangerous Goods Board and includes addenda issued to the 2015–2016 edition of the ICAO Technical Instructions.
Where are there gaps in the global clinical trial supply chain? Sam Herbert, President of World Courier, discusses...
Africa is the second largest of the earth’s seven continents and makes up approximately 22% of the earth’s total land area. We take a look at some of the challenges this poses on logistics.
George Low, Director of Southeast Asia for World Courier, explains how manufacturer's expectations of specialty logistics companies are changing in Asia-Pac.
Global logistics will always be challenging..and sometimes, even out of this world...
Explore some of the trends in temperature-controlled transport
World Courier, a recognized leader in specialty logistics for global clinical trials, discusses the importance of adopting a robust and flexible risk management strategy for transporting pharmaceuticals in light of forthcoming regulation.
Discover why there is a demand for more targeted logistics solutions, particularly in the clinical trials arena.
How sustainability efforts change your supply chain for the better...
A visual history of cold chain packaging evolution through the decades
Scandinavia and Nordic progression with clinical trials
We shed light on the inventory management challenges inherent in global clinical trials, as well as strategic considerations for conducting trials in emerging markets.
The impact of the FMD on the Supply chain.
In this interview, Jaqueline shares her perspective on LATAM success and the value World Courier brings to this growing market.
Five misconceptions about Global Specialty Transport
Counterfeit drugs remain a supply chain risk in emerging markets
What you need to know to ensure integrity
Inappropriate drug storage can reduce the quality of the product, so patients and investigators must be aware of the risks
Corruption can be a huge hurdle when it comes to global expansion. Are you ensuring best business conduct across the globe?
Thailand is becoming more like other, more developed markets in the region, and as part of the ASEAN region, it offers excellent opportunities. Growth is expected in both clinical and commercial prospects.
Six trends in temperature-controlled transport
What can pharma do to prioritize patient safety while ensuring efficiency? Part 2
Learn about the five steps you can take to help prevent any temperature excursions during your shipments with our white paper
Although the world of specialty logistics may be growing smaller, it does not mean it is getting any less complex...
After a 6,250 mile journey from Bolivia to Scotland, the samples from the APEX 4 expedition are being analyzed by the University of Edinburgh...
Ruediger Lomb, Vice President, Global Quality and Technical Compliance at World Courier, discusses the current regulatory challenges that are impacting the specialty logistics industry.
When it comes to clinical research, an already small world continues to grow even smaller. In no area is this more evident than site selection for clinical trials.
Learn how to protect your supply chain against counterfeit drugs with our white paper
In this two-part webinar, we discuss how the supply chain has evolved and how manufacturers can really get distribution right.
.jpg?h=320&iar=0&w=540&useCustomFunctions=1¢erCrop=1&hash=31E00931176438BB94A402A98C4B5624)
.jpg?h=320&iar=0&w=540&useCustomFunctions=1¢erCrop=1&hash=46F1DAD400F81BCEBB3D04B0A8D757F2)
.jpg?h=320&iar=0&w=540&useCustomFunctions=1¢erCrop=1&hash=BEB1143FEB8A1E2AA74F394DAC9C2EC0)
.jpg?h=320&iar=0&w=540&useCustomFunctions=1¢erCrop=1&hash=FFAD46B50DC7BAF96943931DC619FE9D)
.jpg?h=320&iar=0&w=540&useCustomFunctions=1¢erCrop=1&hash=A24FECA9C9A36CF9E118BFB1F6855B5D)
.jpg?h=56&iar=0&w=56&useCustomFunctions=1¢erCrop=1&hash=5C3BF081DEFE0CD4643E0D660948B3B2)
.jpg?h=320&iar=0&w=540&useCustomFunctions=1¢erCrop=1&hash=A0E2703FF178771B1EDD89EFC5F07029)
.jpg?h=320&iar=0&w=540&useCustomFunctions=1¢erCrop=1&hash=DEA81FE4A2223DF4FABF912510B699F7)
.jpg?h=320&iar=0&w=540&useCustomFunctions=1¢erCrop=1&hash=270DD3B1DF5FE745FD13ECA1BF898BFC)
